JOURNAL OF CLINICAL PATHOLOGY

Scope & Guideline

Transforming Findings into Clinical Practice

Introduction

Welcome to the JOURNAL OF CLINICAL PATHOLOGY information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF CLINICAL PATHOLOGY, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0021-9746
PublisherBMJ PUBLISHING GROUP
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1948 to 2024
AbbreviationJ CLIN PATHOL / J. Clin. Pathol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressBRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND

Aims and Scopes

The Journal of Clinical Pathology focuses on advancing the field of clinical pathology through the dissemination of high-quality research and clinical insights. It encompasses a broad range of topics essential to the practice of pathology and laboratory medicine, aiming to improve diagnostic accuracy and patient care.
  1. Clinical and Diagnostic Pathology:
    The journal emphasizes research that enhances diagnostic methodologies, including histopathology, cytopathology, and molecular diagnostics, aiming to improve the accuracy and utility of laboratory tests in clinical settings.
  2. Molecular Pathology and Genetics:
    There is a strong focus on the molecular aspects of pathology, including genetic testing, biomarker discovery, and the understanding of molecular alterations in various diseases, particularly cancers.
  3. Laboratory Medicine and Quality Improvement:
    Research on laboratory practices, quality assurance, and the implementation of new technologies in pathology laboratories is a significant aspect, aiming to enhance laboratory efficiency and diagnostic outcomes.
  4. Transfusion Medicine and Hematopathology:
    The journal covers studies related to transfusion practices, blood banking, and hematopathology, addressing both clinical and laboratory challenges in these areas.
  5. Emerging Infectious Diseases and Public Health:
    Research related to the pathology of infectious diseases, particularly those with public health implications, is a core area, especially in light of recent global health crises.
  6. Artificial Intelligence and Digital Pathology:
    The journal explores the integration of artificial intelligence and digital technologies in pathology to enhance diagnostic accuracy, workflow efficiency, and educational opportunities.
The Journal of Clinical Pathology has identified several emerging themes in pathology research that highlight the evolving landscape of clinical diagnostics and patient care. These trends are significant for researchers and practitioners looking to stay at the forefront of the field.
  1. Integration of Artificial Intelligence:
    There is a growing trend in utilizing artificial intelligence to enhance diagnostic processes, automate workflows, and improve the accuracy of pathology results, indicating its importance in future pathology practices.
  2. Molecular Diagnostics and Personalized Medicine:
    An increase in research focusing on molecular diagnostics, including genetic profiling and targeted therapies, reflects a shift towards personalized medicine in pathology, particularly in oncology.
  3. Pathology Education and Training Innovations:
    Emerging themes include innovative educational approaches for pathology training, such as virtual learning and competency-based assessments, which are crucial for developing future pathologists.
  4. Public Health and Infectious Disease Research:
    The journal is increasingly publishing studies related to public health concerns and infectious diseases, particularly in response to the COVID-19 pandemic, emphasizing the role of pathology in global health.
  5. Quality Improvement Initiatives:
    There is a notable trend towards research that focuses on quality improvement in laboratory practices, including reducing errors, enhancing patient safety, and optimizing test utilization.

Declining or Waning

While the Journal of Clinical Pathology continues to thrive in several areas, some topics have seen a notable decline in publication frequency. These waning scopes may reflect shifts in research priorities or advancements in alternative methodologies.
  1. Traditional Cytology Techniques:
    There has been a decreasing emphasis on traditional cytology methods, as advancements in molecular diagnostics and imaging techniques provide more accurate and efficient diagnostic options.
  2. Basic Hematology Studies:
    Research focusing solely on basic hematology without incorporating molecular or advanced imaging techniques has become less prominent, indicating a shift towards more integrated approaches.
  3. Older Diagnostic Protocols:
    The journal has seen fewer publications on outdated diagnostic protocols and methodologies that do not align with current best practices in pathology and laboratory medicine.
  4. Non-Specific Infectious Disease Studies:
    Research that lacks specificity or does not incorporate modern diagnostic techniques, such as molecular diagnostics, has decreased, reflecting a trend towards more targeted and precise studies.

Similar Journals

JOURNAL OF MOLECULAR DIAGNOSTICS

Elevating the standards of diagnostic excellence in healthcare.
Publisher: ELSEVIER SCIENCE INCISSN: 1525-1578Frequency: 12 issues/year

The Journal of Molecular Diagnostics is a premier publication in the fields of molecular medicine and pathology, published by Elsevier Science Inc. With an impressive impact factor and recognized as a Q1 journal in both Molecular Medicine and Pathology and Forensic Medicine, this journal is dedicated to advancing the understanding and application of molecular diagnostics in clinical practice. The journal features rigorous peer-reviewed research, comprehensive reviews, and cutting-edge methodologies that highlight novel diagnostic tests and biomarkers. Researchers, professionals, and students in the biomedical sciences are invited to explore its diverse array of articles and contribute to a growing body of knowledge critical for innovation in healthcare delivery. Located in the Netherlands, the journal has secure its position among the top-tier journals with its recent Scopus ranking of 20th out of 208 in Medicine Pathology and Forensic Medicine, reflecting a strong percentile ranking of 90th. With coverage spanning from 1999 to 2024, the Journal of Molecular Diagnostics remains a vital resource for anyone committed to the future of molecular research and diagnostics.

LABORATORY INVESTIGATION

Enriching Knowledge in Pathology and Forensic Medicine
Publisher: ELSEVIER SCIENCE INCISSN: 0023-6837Frequency: 12 issues/year

Laboratory Investigation is a premier academic journal published by Elsevier Science Inc, specializing in the fields of Pathology, Forensic Medicine, Cell Biology, and Molecular Biology. With its ISSN 0023-6837 and E-ISSN 1530-0307, this journal has been a significant contributor to scientific discourse since its inception in 1952, converging into its current form by 2024. It holds an impressive standing in its respective fields, featuring a 2023 Journal Rank of Q2 in both Cell Biology and Molecular Biology, and an elite Q1 ranking in Pathology and Forensic Medicine, reflecting its influence and quality of research, as seen in its Scopus ranks—17th out of 208 in Pathology and Forensic Medicine. Although it does not offer Open Access options, the journal remains a vital resource for researchers, professionals, and students who seek to disseminate and engage with high-caliber research findings. The importance of Laboratory Investigation is underscored by its commitment to advancing the understanding of laboratory and translational medicine, paving the way for innovations that enhance clinical practices.

Clinical Laboratory

Innovating Insights in Laboratory Medicine
Publisher: CLIN LAB PUBLISSN: 1433-6510Frequency: 12 issues/year

Clinical Laboratory is a reputable journal dedicated to the interdisciplinary field of clinical biochemistry, genetics, and molecular biology. Published by CLIN LAB PUBL in Germany, this journal provides a platform for the dissemination of original research, reviews, and key insights into laboratory practices and innovations that play a crucial role in modern medicine and diagnostics. With an ISSN of 1433-6510 and a consistent publication history since its inception in 1964 and converging through 2024, it is indexed within the Scopus database, ranking in the 30th percentile among its peers. Although classified in the third quartile for 2023 in the field, Clinical Laboratory continues to contribute valuable knowledge and fosters collaboration among researchers, professionals, and students. Notably, it does not currently operate as an Open Access journal, which emphasizes its commitment to maintaining high-quality peer-reviewed content accessible through institutional and library subscriptions. For those in the domain, Clinical Laboratory serves as a vital resource for the latest advancements and trends shaping the future of clinical laboratory science.

Clinical Pathology

Driving Excellence in Clinical Pathology Scholarship
Publisher: SAGE PUBLICATIONS LTDISSN: 2632-010XFrequency: 1 issue/year

Clinical Pathology, an esteemed journal published by SAGE Publications Ltd, stands at the forefront of advancing knowledge in the intersection of histology, microbiology, and pathology. As an Open Access journal since 2019, it provides researchers and healthcare professionals seamless access to high-quality, peer-reviewed articles that contribute to the field's growing body of knowledge. With a focus on enhancing diagnostic methodologies and advancing clinical applications, Clinical Pathology serves a diverse audience eager to explore innovative research and practical insights. The journal currently holds Q3 status in Histology and Pathology and Forensic Medicine, and Q4 in Medical Microbiology, reflecting its commitment to rigorous scholarship within a competitive landscape. Its ranking in Scopus further positions it as a vital resource for professionals striving for excellence in clinical and experimental pathology. We invite researchers, students, and professionals to engage with the latest findings and share their valuable contributions to help propel the field forward.

PATHOLOGICA

Exploring Innovations in Pathology for a Healthier Tomorrow.
Publisher: PACINI EDITOREISSN: 0031-2983Frequency: 4 issues/year

PATHOLOGICA is a leading academic journal dedicated to the field of pathology and forensic medicine, published by PACINI EDITORE. With a rich history dating back to its inception in 1945, the journal has consistently contributed to the advancement of knowledge in these vital areas of medical research and practice. Currently ranked in the Q1 quartile for Pathology and Forensic Medicine and holding an impressive position as #42 out of 208 in the Scopus rankings, it reflects a significant impact within the academic community, boasting an 80th percentile ranking. The journal is committed to publishing high-quality, peer-reviewed articles that explore innovative research findings and clinical advancements, making it an essential resource for researchers, clinicians, and students alike. Though it does not offer open access, PATHOLOGICA continues to foster scholarly communication by disseminating cutting-edge research findings, thus playing a pivotal role in enhancing pathology education and practice worldwide.

SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Fostering innovation in clinical diagnostics.
Publisher: TAYLOR & FRANCIS LTDISSN: 0036-5513Frequency: 8 issues/year

The Scandinavian Journal of Clinical & Laboratory Investigation is a premier publication in the fields of clinical biochemistry and laboratory medicine, published by Taylor & Francis Ltd in the United Kingdom. With an ISSN of 0036-5513 and E-ISSN 1502-7686, this journal has been a vital source of scholarly articles since its inception in 1949, and is set to celebrate over seventy-five years of contributing to scientific knowledge in 2024. Ranked in the Q2 category for both Clinical Biochemistry and Medicine (Miscellaneous), it holds a robust position within the Scopus rankings, with a commendable rank of 77/117 in its discipline. The journal is dedicated to advancing research by offering a platform for high-quality studies that explore the development and application of clinical and laboratory investigations, making it essential reading for researchers, practitioners, and students interested in the latest advances and methodologies in the field. Although it does not currently offer Open Access, a wealth of valuable research insights awaits readers within its pages, highlighting its crucial role in fostering communication and innovation in clinical sciences.

JOURNAL OF COMPARATIVE PATHOLOGY

Enhancing Diagnostic Accuracy Through Comparative Studies
Publisher: ELSEVIER SCI LTDISSN: 0021-9975Frequency: 6 issues/year

JOURNAL OF COMPARATIVE PATHOLOGY, published by Elsevier Science Ltd, stands as a significant publication within the fields of pathology and forensic medicine, as well as veterinary studies. With an ISSN of 0021-9975 and an E-ISSN of 1532-3129, this journal has been disseminating critical research since 1950, contributing to the advancement of knowledge through its focus on comparative pathology. The journal's reputable standing is underscored by its Q3 classification in Pathology and Forensic Medicine and Q2 in Veterinary (miscellaneous) for 2023, reflecting its vital role in shaping contemporary discourse in these domains. The Scopus ranks further solidify its presence, placing it at the 51st percentile in general veterinary sciences and the 32nd percentile in pathology—a testament to the quality and relevance of the contributions it publishes. Although it operates under a subscription model, the journal remains accessible to researchers and practitioners who aim to deepen their understanding of pathological phenomena across species, enhance diagnostic accuracy, and improve clinical practices. With a steadfast commitment to rigorous peer review and a global readership, the JOURNAL OF COMPARATIVE PATHOLOGY is an essential resource for those engaged in research and professional practice, fostering collaborations and innovations that bridge complementary areas of study.

HISTOPATHOLOGY

Elevating Research in Forensic Medicine and Diagnostics
Publisher: WILEYISSN: 0309-0167Frequency: 12 issues/year

HISTOPATHOLOGY is a premier scholarly journal published by WILEY, targeting the fields of histology, pathology, and forensic medicine. With an ISSN of 0309-0167 and an E-ISSN of 1365-2559, this esteemed journal has maintained a strong academic presence since its inception in 1977. Boasting an impressive Q1 ranking in crucial categories such as Histology and Pathology, it ranks 13th out of 208 in Pathology and Forensic Medicine, and 5th out of 62 in Histology, reflecting its high impact and relevance within the scientific community. HISTOPATHOLOGY serves as a critical platform for disseminating significant research findings, reviews, and advancements in the diagnostic and therapeutic aspects of pathology. Although it does not operate under an open access model, its rigorous peer-review process ensures that published articles uphold the highest standards of scientific integrity. Scholars and practitioners alike benefit from the insights shared in this journal, as it aims to bridge the gap between laboratory science and clinical practice, fostering innovation and enhancing our understanding of disease mechanisms.

Annals of Laboratory Medicine

Advancing the Frontiers of Laboratory Medicine
Publisher: KOREAN SOC LABORATORY MEDICINEISSN: 2234-3806Frequency: 6 issues/year

Annals of Laboratory Medicine, published by the KOREAN SOC LABORATORY MEDICINE, stands as a pivotal resource for researchers and practitioners in the fields of clinical and medical biochemistry. With a strong Q2 ranking in both Biochemistry (medical) and Clinical Biochemistry, along with a prestigious Q1 status in miscellaneous Medicine categories, this journal emphasizes the significance of laboratory medicine in improving patient outcomes and advancing scientific understanding. Established in 2012, the journal has demonstrated an impressive trajectory of growth and scholarly contribution, making it a reliable source of high-quality research and insightful reviews. The journal utilizes open access, enhancing the reach of its findings across the global scientific community. Operating from South Korea, Annals of Laboratory Medicine aims to foster dialogue and collaboration among professionals, contributing to the continuous advancement of laboratory methodologies and diagnostics.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Unveiling Innovations in Diagnostic Techniques
Publisher: TAYLOR & FRANCIS ASISSN: 1473-7159Frequency: 12 issues/year

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, published by Taylor & Francis AS, serves as a pivotal platform for facilitating advanced research and discourse in the fields of Genetics, Molecular Biology, Molecular Medicine, and Pathology. With an impressive Impact Factor and a distinguished status as Q2 in multiple categories, along with a prestigious Q1 ranking in Pathology and Forensic Medicine (2023), this journal continues to attract contributions from leading experts and budding researchers alike. The journal aims to address critical developments in molecular diagnostics, providing insightful reviews that propel the understanding and application of diagnostic techniques in various medical contexts. Accessible to a diverse audience in the academic community, the journal emphasizes the importance of molecular diagnostics in both clinical and laboratory settings, promoting innovative methodologies and comprehensive evaluations of emerging technologies. With ongoing convergence of scientific discovery advancing rapidly from 2001 through 2024, EXPERT REVIEW OF MOLECULAR DIAGNOSTICS remains essential for those committed to furthering the fields of molecular diagnostics and healthcare advancements globally.